Bibliography
- KNIGHT R: Therapeutic possibilities in CJD: patents 1996–1999. Exp. Opin. Ther. Patents (2000) 10:49-57. Recent review of other relevant patents.
- HEAD MW, IRONSIDE JW: Inhibition of prion-protein conversion: a therapeutic tool? Trends Microbiol. (2000) 8:6–8.
- TATZELT J, PRUSINER SB, WELCH WJ: Chemical chaper-ones interfere with the formation of scrapie prion protein. EMBO J. (1996) 15:6363–6373.
- KORTH C, STIERLI B, STREIT P et al.: Prion(PrPSc)-specific epitope defined by a monoclonal antibody. Nature (1997) 390:74–77.
- CASPI S, HALIMI M, YANAI A et al: The anti-prion activityof congo red. J. Biol. Chem. (1998) 273:3484–3489.
- TAGLIAVINI F, MCARTHUR RA, CANCIANI B et al.:Effectiveness of anthracycline against experimental prion disease in Syrian hamsters. Science (1997) 276:1119–1122.
- KUNER P, BOHRMANN B, TJERNBERG LO et al.: Control-ling polymerization of I3-amyloid and prion-derived peptides with synthetic small molecule ligands. J. Biol. Chem. (2000) 275:1673–1678.
- PERRIER V, WALLACE AC, KANEKO K et al.: Mimickingdominant negative inhibition of prion replication through structure-based drug design. Proc. Natl. Acad. Sci. USA (2000) 97:6073–6078.
- CAUGHEY B, RAYMOND GJ: Sulfated polyanion inhibi-tion of scrapie-associated PrP accumulation in cultured cells. J. Vim]. (1993) 67:643–650.
- PEREZ M, WANDOSELL F, COLACO C, AVILA J: Sulphated glycosaminoglycans prevent the neurotoxicity of a human prion protein fragment. Biochem. J. (1998) 335:369–374.
- CHABRY J, PRIOLA SA, WEHRLY K, NISHIO J, HOPE J,CHESEBRO B: Species-independent inhibition of abnormal prion protein (PrP) formation by a peptide containing a conserved PrP sequence. j Vim/ (1999) 73:6245–6250.
- SOTO C, KASCSAK RJ, SABORIO GP et al: Reversion of prion protein conformational changes by synthetic I3-sheet breaker peptides. Lancet (2000) 355:192–197.
- SUPATTAPONE S, NGUYEN HO, COHEN FE, PRUSINER SB, SCOTT MR: Elimination of prions by branched polyamines and implications for therapeutics. Proc. Natl. Acad. Sci. USA (1999) 96:14529–14534.
- CAUGHEY WS, RAYMOND LD, HORIUCHI M, CAUGHEY B: Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines. Proc. Natl. Acad. Sci. USA (1998) 95:12117–12122.
- ••In vitro effects of tetrapyrroles.
- PRIOLA SA, RAINES A, CAUGHEY WS: Porphyrin and antiscrapie compounds. Science (2000) 287:1503–1506.
- ••In vivo effects of tetrapyrroles.